Rapid-Sequence Phosphorus-31 Magnetic Resonance Spectroscopy of the Human Heart Using a 1.5-T Clinical System

Acta Radiologica

Volumn 45, Issue 1, 2004, Pages 30-37

  Chida, K ^a   Saito, H ^b   Nagasaka, T ^b   Otani, H ^b   Kohzuki, M ^b   Zuguchi, M ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b NONE

Author keywords

Heart; High energy phosphates; MR spectroscopy; Myocardium

Indexed keywords

DISEASES; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; PATIENT MONITORING; PHOSPHORUS; SIGNAL TO NOISE RATIO;

HIGH-ENERGY PHOSPHATES; MYOCARDIUM;

CARDIOLOGY;

PHOSPHORUS;

ADULT; ARTICLE; COMPARATIVE STUDY; HEART; HUMAN; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SCINTISCANNING; TIME;

ADULT; HEART; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHANTOMS, IMAGING; PHOSPHORUS; TIME FACTORS;

EID: 1642301116     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841850410003284     Document Type: Article

References (15)

1. Beer M, Sandstede J, Landschutz W, et al. Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans. Eur Radiol 2000;10:1323-8.
2. Blamire AM, Rajagopalan B, Radda GK. Measurement of myocardial pH by saturation transfer in man. Magn Reson Med 1999;41:198-203.
3. Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology 1994;191:593-612.
4. Buchthal SD, den Hollander JA, Merz CN, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2001;342:829-35.
5. 31P-MRS of the human heart using a 1.5-Tesla (T) clinical imager. Radiology 2002;Suppl 225:702.
6. Conway A, Bottomley PA, Ouwerkerk R, et al. Mitral regurgitation impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation 1998;97:1716-23.
7. Hetherington HP, Luney DJ, Vaughan JT, et al. 3D 31P spectroscopic imaging of the human heart at 4.1 T. Magn Reson Med 1995;33:427-31.
8. Henriksen O. MR spectroscopy in clinical research. Acta Radiol 1994;35:96-116.
9. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536-42.
10. Kallil-Filho R, Albuquerque CP, Weiss RG, et al. Normal high energy phosphate ratios in 'Stunned' human myocardium. J Am Coll Cardiol 1997;30:1228-32.
11. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190-6.
12. 31P-magnetic resonance spectroscopy. J Investig Med 1997;45:453-62.
13. Pohmann R, von Kienlin M, Haase A. Theoretical evaluation and comparison of fast chemical shift imaging methods. J Magn Reson 1997;129:145-60.
14. von Kienlin M, Beer M, Greiser A, et al. Advances in human cardiac 31P-MR spectroscopy: SLOOP and clinical applications. J Magn Reson Imag 2001;13:521-7.
15. Weiss RG, Kallil-Filho R, Bottomley PA. Clinical cardiac magnetic spectroscopy. In: Manning WJ, Pennell DJ, editors. Cardiovascular magnetic resonance. New York: Churchill Livingstone; 2002. p. 437-46.